Skip to main content
Plastic and Reconstructive Surgery Global Open logoLink to Plastic and Reconstructive Surgery Global Open
. 2025 Aug 12;13(8):e7065. doi: 10.1097/GOX.0000000000007065

Cosmetic Tourism: A Cost-utility Analysis of Abdominoplasty Performed in the United States and Abroad

Morvarid Mehdizadeh *, Angelica Hernandez Alvarez *, Joshua A Bloom *, Justin J Cordero *,†, Iulianna Taritsa *, Daniela Lee *, Samuel J Lin *,✉
PMCID: PMC12342123  PMID: 40799465

Abstract

Background:

Rising abdominoplasty costs in the United States have driven patients to seek affordable options abroad despite risks, fueling the medical tourism industry. This study compared the cost-effectiveness of abdominoplasty performed in the United States versus abroad.

Methods:

Patients presenting to an academic hospital’s emergency department with complications from out-of-state/country abdominoplasties (2018–2022) were surveyed. Utility scores were obtained from the survey and used to calculate quality-adjusted life years (QALYs) for each health state. Probabilities and outcomes were obtained by literature review, and a decision-analysis tree was constructed with rollback analysis to determine the more cost-effective strategy. An incremental cost-utility ratio was calculated with a willingness-to-pay threshold of $100,000 per QALY. Deterministic and probabilistic sensitivity analyses were performed.

Results:

Cosmetic tourism abdominoplasty was associated with a lower clinical effectiveness (QALY 39.08) compared with abdominoplasty in the United States (39.09), and a relative cost decrease of $2066.26. The incremental cost-utility ratio of $811,471.83 per QALY did not result in cosmetic tourism abdominoplasty being cost-effective. Although the lower costs of cosmetic tourism are appealing, the marginal difference in clinical effectiveness raises concerns about the overall value. In the case that the cost of the cosmetic tourism abdominoplasty was less than $7061.63, 1-way sensitivity analyses showed that this option was more cost-effective than abdominoplasty in the United States, with 68.03% Monte Carlo confidence.

Conclusions:

Cosmetic tourism abdominoplasty may be cost-effective only when priced less than $7061.63. This analysis may inform patients’ reservation prices, considering postoperative complications, follow-up, and long-term relationships with healthcare providers.


Takeaways

Question: What is the cost-effectiveness of abdominoplasty performed abroad compared with that performed in the United States, considering postoperative complications and quality-adjusted life years?

Findings: This cost-utility analysis used survey data and a decision-analysis model to compare outcomes. Abdominoplasty via cosmetic tourism is cost-effective only when its cost is less than $7061.63, but complications may significantly impact clinical effectiveness and healthcare costs.

Meaning: Although cosmetic tourism may seem financially appealing, patients must weigh the risks of complications and consider the long-term value of care provided in the United States.

INTRODUCTION

Cosmetic surgery tourism has increased in popularity, evolving into a major global industry.1–3 Several factors may influence an individual’s decision to travel abroad for aesthetic plastic surgery, such as perceived lower costs, cultural familiarity with the surgeon, or access to treatments unavailable or unapproved in the United States.4 One common elective surgery that is pursued by patients looking for lower costs abroad is the abdominoplasty procedure, or the tummy tuck, which averages $8174 in the United States.5

Although cost savings for an elective surgery abroad may be appealing, individuals who undergo abdominoplasty abroad may experience postoperative complications requiring treatment in their home state. Studies on cosmetic tourism complications and their healthcare impact have increased in recent years.6,7 Adabi et al8 noted that managing complications of cosmetic surgery tourism may cost an average of $18,211 per individual, with an estimated total impact on the US healthcare system reaching $1.33 billion. Moreover, the Centers for Disease Control and Prevention published a 2024 report revealing 93 deaths among US citizens after cosmetic surgery in the Dominican Republic between 2009 and 2022, with an increasing trend in fatalities in the later years of the study.9 There may be various reasons contributing to these complications after cosmetic surgery tourism, including differing surgical standards, poor continuity of care, and limited follow-up abroad.1,2

Despite this, limited literature evaluates the cost-effectiveness of cosmetic surgery tourism procedures such as abdominoplasty.10 With increasing popularity of cosmetic surgery tourism and the burden on healthcare resources for managing postoperative complications, an objective economic assessment of cosmetic tourism abdominoplasties is crucial to optimize patient outcomes. Quality-adjusted life years (QALYs) is 1 metric that may examine the cost-effectiveness of such interventions by combining life quality and duration, which may enable the comparison of surgical outcomes, particularly when complications impact recovery and long-term satisfaction.11

The purpose of this study was to highlight the need for evidence to inform patients about the true cost-effectiveness of undergoing abdominoplasty performed by means of cosmetic tourism, whether domestically or internationally, while accounting for postoperative complications and outcomes measured through QALYs. The findings of this study may be helpful for both surgeons and patients who are seeking elective cosmetic abdominoplasties to consider the various factors that may influence the patient’s decision-making process.

METHODS

Study Participants

This study was reviewed and deemed exempt by our institutional review board (protocol no. 2023P000740). Patients presenting to the emergency department of an urban tertiary academic hospital with complications from abdominoplasty performed out of state or country between the years 2018 and 2022 were identified, and their charts were retrospectively reviewed. They were then contacted to distribute an electronic Research Electronic Data Capture (REDCap) survey.

As first contact, a recruitment letter was sent to the patient’s address provided during their emergency department visit, with information about the study and how to opt out of future communication. After 14 days, patients who did not opt out were contacted by phone, up to 3 times, to obtain verbal informed consent to participate in the survey. Consented patients were given the option to complete the survey over the phone or online. If a patient preferred to complete the survey online, they received a link to the REDCap survey either through email or via text message to their phone. (See figure, Supplemental Digital Content 1, which displays the recruitment letter, https://links.lww.com/PRSGO/E274.) (See figure, Supplemental Digital Content 2, which displays the prospective agreement, https://links.lww.com/PRSGO/E275.) (See figure, Supplemental Digital Content 3, which displays the patient survey, https://links.lww.com/PRSGO/E276.)

Survey Design

A 10-question anonymous electronic REDCap survey was designed to evaluate quality of life and cost-effectiveness in patients who underwent abdominoplasty outside their home state or country and subsequently sought emergency care at a tertiary academic hospital. Utility-based assessments of various hypothetical postsurgical complications measured patients’ perceptions of the quality of life associated with various surgical outcomes, patient age, the country or state in which their abdominoplasty was performed, the estimated cost of the procedure, and whether they would consider ever having another elective procedure done outside their state or country. The utility assessments scored on a scale from 0 (death) to 100 (perfect health) for a series of abdominoplasty complications, including seroma, hematoma, wound dehiscence, infection, necrosis, hospital floor admission, and intensive care unit admission. The scores provided insight into the perceived impact of the complication on quality of life and were used to calculate QALYs for each health state. A utility scale was provided for reference (Supplemental Digital Content 3, https://links.lww.com/PRSGO/E276).

Reference Case

In this cost-utility model, the base case was defined as a 40-year-old female patient with excess infraumbilical skin and rectus diastasis. In this hypothetical scenario, the patient could undergo either abdominoplasty by means of cosmetic tourism or abdominoplasty in their home state. Life expectancy of the patients in this cohort from the time of surgery was estimated to be 39.1 years based on current data from the Centers for Disease Control and Prevention.

Decision Tree and Probabilities

We used TreeAge Software Pro Version 2020 (TreeAge Software, Inc., Williamstown, MA) to construct the decision model and compare both scenarios (Fig. 1). In this model, under each arm of the decision tree, the probabilities, costs, and utilities of each health state were incorporated. Both interventions had the same postoperative outcomes: successful surgery, seroma, hematoma, infection, wound dehiscence, and skin necrosis. Successful surgery was defined as surgery without any of these complications. A literature review was performed on PubMed to obtain the probabilities and outcomes for abdominoplasty performed in the United States compared with those for cosmetic tourism abdominoplasty. Two independent reviewers screened titles and abstracts, independently reviewed full-text articles to assess relevance, and abstracted and recorded findings. After data abstraction, both reviewers compared their extracted data for consistency, and any disagreements were resolved through discussion or by consulting a third senior reviewer.

Fig. 1.

Fig. 1.

Decision tree constructed with rollback analysis to determine the more cost-effective strategy. The top green line represents the more cost-effective strategy.

Costs and Perspectives

This model was constructed from the perspective of the third-party payer, which is well described in the literature.12–24 Costs of abdominoplasty were derived from survey data. Publicly available cost data from 2024 Medicare Current Procedure Terminology codes were used to calculate the costs of complications. Direct surgical costs of abdominoplasty, as well as associated costs of each health state, were reported in 2024 US dollars (Table 1). Of note, this model did not include any indirect costs such as flights, accommodation, transportation, or other expenses.

Table 1.

Utilities, CPT, and Cost

Health State Utility Score CPT Cost, US Dollars* SD, US Dollars
Abdominoplasty via cosmetic tourism 1 Cosmetic fee 5365.23 3000
+ Successful surgery 1 Cosmetic fee 5250.00
+ Seroma 0.57 (4 wk) + 10,140 5397.08
+ Hematoma 0.57 (4 wk) + 10,140 5397.08
+ Infection 0.46 (4 wk) + 10,180 5467.73
+ Wound dehiscence 0.53 (12 wk) + 14,001 6330.44
+ Skin necrosis 0.39 (12 wk) + 11,042, 14,001 6407.54
Abdominoplasty in the United States 1 Cosmetic fee 7431.49 3000
+ Successful surgery 1 Cosmetic fee 7337.50
+ Seroma 0.57 (4 wk) + 10,140 7484.58
+ Hematoma 0.57 (4 wk) + 10,140 7484.58
+ Infection 0.46 (4 wk) + 10,180 7555.23
+ Wound dehiscence 0.53 (12 wk) + 14,001 8417.94
+ Skin necrosis 0.39 (12 wk) + 11,042, 14,001 8495.04
*

Baseline cost is derived from 2024 Medicare CPT reimbursement.

CPT, Current Procedural Terminology.

Utility Scores

Utility scores were obtained for each health state as detailed in the Survey Design section. Patients with minor complications (seroma, hematoma, and infection) were estimated to recover within 4 weeks and return to the baseline utility score of a successful surgery. Wound dehiscence and skin necrosis were estimated to take 12 weeks to return to baseline, accounting for the longer healing time.

The following example illustrates how QALY was obtained for our 40-year-old patient. Similar examples have been published in our past work.12–18 Life expectancy for an average American is 79.1 years (according to data from the National Center for Health Statistics). Therefore, for a 40-year-old patient, life expectancy is 39.1 years. A patient with a seroma undergoing abdominoplasty in the United States is expected to have a utility of 0.57 and recover within 4 weeks. The utility of a successful surgery without complication is 1.0.

• Numberofhealthyearsremaining =averagelifeexpectancy–averageageofpatient:  79.1–40years=39.1years. 
• Durationofhealthstate: 4weeks52weeks=0.077years. 
• QALY: (Utility of health state)×(duration of health state) +(utility of successful procedure)×(remaining life years):  (0.57)(0.077)+(1.0)(39.1–0.077)=39.07QALYs. 

Incremental Cost-utility Ratio

An incremental cost-utility ratio (ICUR) was then calculated using the following formula:

ICUR=Expected cost of abdominoplasty via cosmetic tourism −expected cost of abdominoplasty in the United States Expected QALY of abdominoplasty via cosmetic tourism −expected QALY of abdominoplasty in the United States .

A cost-effective approach was defined as an ICUR of less than $100,000.

Sensitivity Analysis

To account for variability in our decision analysis, 2 forms of sensitivity analyses (SAs) were performed. One-way (deterministic) SA was performed for each variable and varied to determine the impact on the result. Probabilistic SA using Monte Carlo simulation was also performed. In this type of SA, the effect of simultaneously changing the values of each variable was evaluated. Variables included in this analysis were cost of abdominoplasty via cosmetic tourism (gamma), cost of abdominoplasty in the United States (gamma), probability of infection for abdominoplasty via cosmetic tourism (beta), probability of seroma for abdominoplasty via cosmetic tourism (beta), and probability of hematoma for abdominoplasty in the United States (beta). All analyses were performed using TreeAge Software Pro Version 2020.

Decision-analysis Quality Assessment

This study was performed in accordance with the consensus guideline recommendations as described by the Consolidated Health Economic Evaluation Reporting Standards criteria.25

RESULTS

Survey Results

A total of 40 patients were identified who met the inclusion criteria, of whom 23 consented to participate and 16 completed the survey. Participants’ age (n = 15) ranged from 30 to 58 years (mean 40.8 y, SD 9.22 y), with only 1 patient (n = 1) not reporting their age on the survey. Regarding the location of the abdominoplasty procedure, 43.8% (n = 7) had their surgery in the Dominican Republic, 6.3% (n = 1) in Mexico, and 50% (n = 8) in Miami. The reported cost of the abdominoplasty (n = 16) varied from $3000 to $12,000 (mean $6293.75, SD $2269.65). When participants were asked if they would consider another elective procedure outside their state or country, given their experience with complications upon return to their home state, 62.5% of respondents (n = 10) indicated they would, whereas 37.5% (n = 6) stated they would not.

Decision Tree Analysis

Abdominoplasty via cosmetic tourism was associated with a lower QALY of 38.08 compared with abdominoplasty in the United States (38.09), with a lower increment of clinical effectiveness of 0.01 and a relative decreased cost of $2066.26. Rollback analysis showed that abdominoplasty via cosmetic tourism is more cost-effective compared with abdominoplasty in the United States, with an ICUR of 811,471.83 (Table 2).

Table 2.

Cost-effectiveness for Each Treatment Arm

Procedure Costs Effectiveness Incremental Cost/QALY
Total Cost, US Dollars Incremental Cost, US Dollars Effectiveness, QALY Incremental Effectiveness ICUR
Abdominoplasty via cosmetic tourism 5365.23 −2066.26 38.08 −0.01 811,471.83
Abdominoplasty in the United States 7431.49 38.09

Deterministic SA

In a 1-way deterministic SA, abdominoplasty via cosmetic tourism remained the more cost-effective strategy if its cost was less than $7061.63 (Fig. 2). A tornado diagram analysis (Fig. 3) identified the cost of abdominoplasty via cosmetic tourism as the greatest variable of uncertainty.

Fig. 2.

Fig. 2.

One-way SA. At WTP of $100,000, abdominoplasty via cosmetic tourism remains the more cost-effective strategy if its cost is less than $7061.63. WTP, willingness to pay.

Fig. 3.

Fig. 3.

Tornado diagram (ICER) identifying the greatest variable of uncertainty as the cost of abdominoplasty via cosmetic tourism. The blue bar represents the portion of the input range from the lower bound to the base case value, and the red bar represents the portion of the input range from the base case value to the upper bound. ICER, incremental cost-effectiveness ratio; WTP, willingness to pay.

Probabilistic SA

The Monte Carlo simulation resulted in a 68.03% confidence in favor of abdominoplasty via cosmetic tourism (Fig. 4).

Fig. 4.

Fig. 4.

Probabilistic SA Monte Carlo acceptability at a WTP of $100,000 resulted in a 68.03% confidence in favor of abdominoplasty via cosmetic tourism. WTP, willingness to pay.

DISCUSSION

In this study, we demonstrated that cosmetic tourism abdominoplasty is a more cost-effective strategy than abdominoplasty in the United States only when the total cost of the abdominoplasty is less than $7061.63. Given that the average reported cost was $5097.23, cosmetic tourism remains cost-effective if indirect costs stay less than $1,964,40. Moreover, although the absolute difference in QALYs between cosmetic tourism abdominoplasty (39.08) and US-based abdominoplasty (39.09) may seem small, in cost-utility analyses, even minor differences in QALYs can have meaningful implications when combined with cost differentials. The ICUR compares the additional cost of 1 intervention over another relative to the additional QALY gained. In cost-utility analyses, if ICUR is less than $100,000 per QALY, the intervention is considered cost-effective. Hence, the ICUR of $811,471.83 per QALY in our study exceeds commonly accepted cost-effectiveness thresholds, suggesting that the cost savings associated with cosmetic tourism do not justify even the marginal decrease in QALYs. These findings align with previous literature suggesting that the allure of lower upfront costs often overlooks the potential for increased postoperative complications and long-term healthcare costs.26–33

Patients are often motivated by perceived cost savings, reduced waiting periods, and familiarity with the destination country.33 However, Adabi et al8 suggested that such patient cost assessments may not be accurate. The authors found that when cosmetic tourism patients were asked about their perceptions of surgical costs for abdominoplasty and breast augmentation in the United States, patients on average estimated the cost to be $9060 higher than the actual rate.8 These findings reflect a misunderstanding of overseas costs and a misrepresentation of cost–benefit analysis.

Although surgical risks are a universal concern for all procedures, they may be heightened in regions where regulations are less strict, and preoperative guidance and postoperative care are less comprehensive.33 Furthermore, patients in the United States have access to hospital safety reports, but there is a lack of accessible safety profiles for international hospitals offering plastic surgery.8 As such, patients seeking procedures abroad often face a dearth of critical information to make a fully informed decision.8 Additional concerns of overseas surgery include, but are not limited to, lack of follow-up, absence of legal protection, dangers of traveling after surgery, exposure to foreign pathogens, and strain on the home country’s healthcare system to address complications upon return.4,8,31,34–40

Studies indicate that when patients travel abroad for procedures, their brief stays and insufficient follow-up care frequently result in them returning to their home country to address any complications that may arise.33,41 Some international studies have described favorable outcomes and best practices in cosmetic tourism, including limiting procedure duration, ensuring hospital-based care, requesting a certified plastic surgeon by the plastic surgery council of the country of interest, and extending postoperative stays for follow-up (eg, 21 d) to monitor for complications.42,43 However, currently these measures are rarely performed in practice. In fact, Ross et al31 showed that only 26% of patients who undergo surgery abroad attend follow-up appointments with the original surgeon and likely receive inadequate preoperative counseling.4,8,33 US surgeons often have limited knowledge of the exact treatments their patients received overseas, complicating the management of complications resulting from overseas procedures.31 Moreover, Ross et al31 also found that upon returning to their home state, 86% of patients relied on their health insurance to cover the costs of follow-up care and complication management, most commonly covered by Medicaid. McAuliffe et al33 reported that the average cost of complication management is $15,083, but it can be up to $154,700 in some cases. These findings underscore the resulting strain such complications place on not only patients and treating healthcare systems but also public insurance systems.4

It is important to acknowledge that cosmetic tourism encompasses not just international travel but also domestic travel. In our study, the most common destination country was the Dominican Republic, and the most common destination state was Florida, consistent with the growing knowledge of medical tourism trends.4,33,44 Previous research has often overlooked cases of domestic tourism in their analyses, focusing only on international cosmetic tourism. In our study, the purpose of our survey was to obtain utility scores from patients who presented to our hospital with complications following cosmetic tourism abdominoplasty. The utility scores were designed to measure patients’ perceptions of the quality of life associated with various hypothetical outcomes, including both successful and complicated scenarios. Therefore, the geographic origin of the patients (eg, Florida, Dominican Republic) does not impact the utility scores themselves, as these scores represent hypothetical assessments rather than outcome data. Although the inclusion of patients in the survey who had surgery in Florida reflects the population of patients who presented to our hospital rather than a deliberate comparison between domestic and international procedures, it does underscore the significant impact that domestic cosmetic tourism can have on local healthcare systems. This highlights the need for a broader understanding and integration of these cases in future studies.

This study is not without limitations. First, there is significant variability in complication rates across different countries, which may affect the generalizability of our results.8,19–24,45–49 The rate of seroma after overseas abdominoplasty was obtained from the global prevalence as reported by Salari et al.19 Owing to the lack of comprehensive data from South American countries, data on postabdominoplasty hematoma, infection, necrosis, and dehiscence rates from Germany were used as a reference for other overseas complications in this study.21 We chose the study from Germany as it was the only overseas publication with availability of structured data on abdominoplasty complications, allowing for standardized comparisons. This limitation could skew the comparative analysis of overseas abdominoplasty more favorably and may not fully reflect the risks associated with surgery in regions with different healthcare standards. Therefore, a 1-way deterministic SA was conducted, which did not alter our conclusion and thereby enhanced the generalizability of our results.

Additionally, as with any survey study, response bias may result in potential underreporting of utility scores to measure patient satisfaction and quality of life following overseas procedures. For example, 1 patient declined participation in the study citing ongoing traumas from the surgical experience, which may have excluded the most severe cases from our analysis. Conversely, response bias may also lead to overreporting by patients with unfavorable experiences. Moreover, although utility scores are useful for quantitative analysis, variations in individual perceptions of complications can influence scoring. For example, patient statements such as “I have a high pain tolerance” or “I did not experience that, so I don’t know” highlight the subjective nature of self-reported outcomes. However, our study adopted the third-party paper perspective.50,51 This perspective provides a standardized framework for evaluating healthcare interventions, focusing on the financial implications for insurance companies or hospital systems rather than individual patient costs, which helps mitigate the limitations of subjective outcomes by emphasizing quantifiable measures. This allowed for a more objective assessment of the economic impact of cosmetic tourism.

This study highlights key areas for future research in cosmetic tourism, particularly abdominoplasty. The most commonly presenting surgical tourism procedure in the United States is abdominoplasty, and 82.7% of overseas tourism cases originate from the Dominican Republic.33 However, there is a dearth of literature presenting the specific complication risks in Latin American countries, and future research should explore the risk of these procedures in destinations where medical tourism is prevalent. Additionally, studies should explore the development and implementation of safety-reporting standards for international cosmetic surgery facilities to establish transparent and accessible safety profiles.8 We also suggest the expansion of accrediting bodies, such as the Joint Commission International, to improve safety and quality in participating facilities.31,33,52 Finally, ethical guidelines for postoperative care abroad are needed to standardize care and improve outcomes.31

CONCLUSIONS

Cosmetic tourism abdominoplasty is a more cost-effective strategy compared with abdominoplasty in the United States only when the cost of the abdominoplasty is less than $7061.63. This analysis may guide an individual’s reservation price when considering factors such as postoperative complications, follow-up, and the longitudinal relationship with their healthcare provider. Future research should focus on improving patient safety standards internationally and providing comprehensive data to enhance patients’ decision-making in the context of medical tourism.

DISCLOSURE

The authors have no financial interest to declare in relation to the content of this article.

Supplementary Material

gox-13-e7065-s001.pdf (144.7KB, pdf)
gox-13-e7065-s002.pdf (823.2KB, pdf)
gox-13-e7065-s003.pdf (235.9KB, pdf)

Footnotes

Published online 12 August 2025.

Presented at the 103rd Annual Meeting of the American Association of Plastic Surgeons, May 27, 2025, Austin, Texas.

Disclosure statements are at the end of this article, following the correspondence information.

Related Digital Media are available in the full-text version of the article on www.PRSGlobalOpen.com.

Morvarid Mehdizadeh and Angelica Hernandez Alvarez contributed equally to this work.

REFERENCES

  • 1.The American Society of Plastic Surgeons. Briefing paper: cosmetic surgery tourism. Available at https://www.plasticsurgery.org/news/briefing-papers/briefing-paper-cosmetic-surgery-tourism. Accessed November 24, 2024.
  • 2.Benowitz I, Gaines J. Medical tourism. In: Brunette GW, Nemhauser JB, eds. CDC Yellow Book 2020: Health Information for International Travel. Oxford University Press; 2019:527–531. [Google Scholar]
  • 3.Franzblau LE, Chung KC. Impact of medical tourism on cosmetic surgery in the United States. Plast Reconstr Surg Glob Open. 2013;1:e63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chin MG, McIntire DRT, Wang MR, et al. Domestic and international cosmetic tourism complications presenting to a US tertiary hospital. Aesthet Surg J. 2024;44:NP829–NP838. [DOI] [PubMed] [Google Scholar]
  • 5.The American Society of Plastic Surgeons. Cosmetic procedures tummy tuck abdominoplasty. Available at https://www.plasticsurgery.org/cosmetic-procedures/tummy-tuck/cost. Accessed November 24, 2024.
  • 6.Klein HJ, Simic D, Fuchs N, et al. Complications after cosmetic surgery tourism. Aesthet Surg J. 2017;37:474–482. [DOI] [PubMed] [Google Scholar]
  • 7.Martin S, Long R, Hill C, et al. Cosmetic tourism in Northern Ireland. Ann Plast Surg. 2019;83:618–621. [DOI] [PubMed] [Google Scholar]
  • 8.Adabi K, Stern CS, Weichman KE, et al. Population health implications of medical tourism. Plast Reconstr Surg. 2017;140:66–74. [DOI] [PubMed] [Google Scholar]
  • 9.Hudson M, Matos JA, Alvarez B, et al. Deaths of U.S. citizens undergoing cosmetic surgery—Dominican Republic, 2009–2022. MMWR Morb Mortal Wkly Rep. 2024;73:62–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sorenson C, Drummond M, Kanavos P. Ensuring Value for Money in Health Care: The Role of Health Technology Assessment in the European Union. WHO Regional Office Europe; 2008. [Google Scholar]
  • 11.Willke RJ, Pizzi LT, Rand LZ, et al. The value of the quality-adjusted life years. Value Health. 2024;27:702–705. [DOI] [PubMed] [Google Scholar]
  • 12.Posawatz D, Bloom J, Massed A, et al. Cost utility of transcatheter aortic valve replacement: Sapien 3 versus CoreValve Evolut R. ASAIO J. 2023;69:475–482. [DOI] [PubMed] [Google Scholar]
  • 13.Bloom JA, Granoff M, Karlsson T, et al. Power-assisted liposuction for lymphedema: a cost-utility analysis. Plast Reconstr Surg Glob Open. 2022;10:e4671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bloom JA, Shah SA, Long EA, et al. Post-mastectomy tissue expander placement followed by radiation therapy: a cost-effectiveness analysis of staged autologous versus implant-based unilateral reconstruction. Ann Surg Oncol. 2023;30:1075–1083. [DOI] [PubMed] [Google Scholar]
  • 15.Bloom JA, Tian T, Homsy C, et al. A cost-utility analysis of the use of closed-incision negative pressure system in vascular surgery groin incisions. Am Surg. 2023;89:2237–2246. [DOI] [PubMed] [Google Scholar]
  • 16.Bloom JA, Asban A, Tian T, et al. A cost-utility analysis comparing immediate oncoplastic surgery with delayed oncoplastic surgery in smoking breast cancer patients. Ann Surg Oncol. 2021;28:2579–2588. [DOI] [PubMed] [Google Scholar]
  • 17.Abosena W, Tedesco A, Han SM, et al. A cost-effectiveness analysis of Wittmann patch-assisted abdominal closure compared to planned ventral hernia in management of the open abdomen. Am Surg. 2024;90:1140–1147. [DOI] [PubMed] [Google Scholar]
  • 18.Bloom JA, Wareham C, Chahine E, et al. A cost-utility analysis of the use of −125 mm Hg closed-incision negative pressure therapy in oncoplastic breast surgery. Plast Reconstr Surg Glob Open. 2024;12:e6163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Salari N, Fatahi B, Bartina Y, et al. The global prevalence of seroma after abdominoplasty: a systematic review and meta-analysis. Aesthetic Plast Surg. 2021;45:2821–2836. [DOI] [PubMed] [Google Scholar]
  • 20.Neaman KC, Hansen JE. Analysis of complications from abdominoplasty: a review of 206 cases at a university hospital. Ann Plast Surg. 2007;58:292–298. [DOI] [PubMed] [Google Scholar]
  • 21.Momeni A, Heier M, Bannasch H, et al. Complications in abdominoplasty: a risk factor analysis. J Plast Reconstr Aesthet Surg. 2009;62:1250–1254. [DOI] [PubMed] [Google Scholar]
  • 22.Salgarello M, Tambasco D, Farallo E. DIEP flap donor site versus elective abdominoplasty short-term complication rates: a meta-analysis. Aesthetic Plast Surg. 2012;36:363–369. [DOI] [PubMed] [Google Scholar]
  • 23.Lesko RP, Cheah MA, Sarmiento S, et al. Postoperative complications of panniculectomy and abdominoplasty: a retrospective review. Ann Plast Surg. 2020;85:285–289. [DOI] [PubMed] [Google Scholar]
  • 24.Kalmar CL, Park BC, Kassis S, et al. Functional panniculectomy vs cosmetic abdominoplasty: multicenter analysis of risk factors and complications. J Plast Reconstr Aesthet Surg. 2022;75:3541–3550. [DOI] [PubMed] [Google Scholar]
  • 25.Husereau D, Drummond M, Petrou S, et al. ; CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BJOG. 2013;120:765–770. [DOI] [PubMed] [Google Scholar]
  • 26.Klein HJ, Simic D, Fuchs N, et al. Complications after cosmetic surgery tourism. Aesthet Surg J. 2017;37:474–482. [DOI] [PubMed] [Google Scholar]
  • 27.Melendez MM, Alizadeh K. Complications from international surgery tourism. Aesthet Surg J. 2011;31:694–697. [DOI] [PubMed] [Google Scholar]
  • 28.Miyagi K, Auberson D, Patel AJ, et al. The unwritten price of cosmetic tourism: an observational study and cost analysis. J Plast Reconstr Aesthet Surg. 2012;65:22–28. [DOI] [PubMed] [Google Scholar]
  • 29.Jeevan R, Armstrong A. Cosmetic tourism and the burden on the NHS. J Plast Reconstr Aesthet Surg. 2008;61:1423–1424. [DOI] [PubMed] [Google Scholar]
  • 30.Birch J, Caulfield R, Ramakrishnan V. The complications of “cosmetic tourism”—an avoidable burden on the NHS. J Plast Reconstr Aesthet Surg. 2007;60:1075–1077. [DOI] [PubMed] [Google Scholar]
  • 31.Ross KM, Moscoso AV, Bayer LR, et al. Plastic surgery complications from medical tourism treated in a U.S. academic medical center. Plast Reconstr Surg. 2018;141:517e–523e. [DOI] [PubMed] [Google Scholar]
  • 32.Snyder J, Crooks VA. New ethical perspectives on medical tourism in the developing world. Dev World Bioeth. 2012;12:iii–ivi. [DOI] [PubMed] [Google Scholar]
  • 33.McAuliffe PB, Muss TEL, Desai AA, et al. Complications of aesthetic surgical tourism treated in the USA: a systematic review. Aesthetic Plast Surg. 2023;47:455–464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Burkett L. Medical tourism. Concerns, benefits, and the American legal perspective. J Leg Med. 2007;28:223–245. [DOI] [PubMed] [Google Scholar]
  • 35.Yakupoglu YK, Ozden E, Dilek M, et al. Transplantation tourism: high risk for the recipients. Clin Transplant. 2010;24:835–838. [DOI] [PubMed] [Google Scholar]
  • 36.Engdahl R, Cohen L, Pouch S, et al. Management of Mycobacterium abscessus post abdominoplasty. Aesthetic Plast Surg. 2014;38:1138–1142. [DOI] [PubMed] [Google Scholar]
  • 37.Rüegg E, Cheretakis A, Modarressi A, et al. Multisite infection with Mycobacterium abscessus after replacement of breast implants and gluteal lipofilling. Case Rep Infect Dis. 2015;2015:361340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Connell J. A new inequality? Privatisation, urban bias, migration and medical tourism. Asia Pac Viewp. 2011;52:260–271. [DOI] [PubMed] [Google Scholar]
  • 39.Bhatt N. Medical Tourism and Plastic Surgery. Montefiore Health System; 2014. [Google Scholar]
  • 40.Gilardi R, Galassi L, Del Bene M, et al. Infective complications of cosmetic tourism: a systematic literature review. J Plast Reconstr Aesthet Surg. 2023;84:9–29. [DOI] [PubMed] [Google Scholar]
  • 41.Pereira RT, Malone CM, Flaherty GT. Aesthetic journeys: a review of cosmetic surgery tourism [published correction appears in J Travel Med. 2018 Jan 1;25(1):tay051. doi: 10.1093/jtm/tay051]. J Travel Med. 2018;25:10.1093/jtm/tay042. [DOI] [PubMed] [Google Scholar]
  • 42.Campbell CA, Restrepo C, Navas G, et al. Plastic surgery medical tourism in Colombia: a review of 658 international patients and 1,796 cosmetic surgery procedures. Plast Reconstr Surg Glob Open. 2019;7:e2233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ramos-Gallardo G, Cárdenas-Camarena L, Cuenca-Pardo J, et al. Medical tourism in plastic surgery, is it possible to keep up this practice? Experience and report of complications in patients operated at beach destinations. Cir Plast. 2023;33:19–27. [Google Scholar]
  • 44.Venditto C, Gallagher M, Hettinger P, et al. Complications of cosmetic surgery tourism: case series and cost analysis. Aesthet Surg J. 2021;41:627–634. [DOI] [PubMed] [Google Scholar]
  • 45.Winocour J, Gupta V, Ramirez JR, et al. Abdominoplasty: risk factors, complication rates, and safety of combined procedures. Plast Reconstr Surg. 2015;136:597e–606e. [DOI] [PubMed] [Google Scholar]
  • 46.Mioton LM, Alghoul MS, Kim JY. A comparative analysis of readmission rates after outpatient cosmetic surgery. Aesthet Surg J. 2014;34:317–323. [DOI] [PubMed] [Google Scholar]
  • 47.Massenburg BB, Sanati-Mehrizy P, Jablonka EM, et al. Risk factors for readmission and adverse outcomes in abdominoplasty. Plast Reconstr Surg. 2015;136:968–977. [DOI] [PubMed] [Google Scholar]
  • 48.Iglesias M, Ortega-Rojo A, Garcia-Alvarez MN, et al. Demographic factors, outcomes, and complications in abdominal contouring surgery after massive weight loss in a developing country. Ann Plast Surg. 2012;69:54–58. [DOI] [PubMed] [Google Scholar]
  • 49.Alderman AK, Collins ED, Streu R, et al. Benchmarking outcomes in plastic surgery: national complication rates for abdominoplasty and breast augmentation. Plast Reconstr Surg. 2009;124:2127–2133. [DOI] [PubMed] [Google Scholar]
  • 50.Blank MM, Papageorge M, Chen L, et al. Hidden bias in cost-analysis research: what is the prevalence of under-reporting cost perspective in the general surgical literature? J Am Coll Surg. 2017;225:823–828.e12. [DOI] [PubMed] [Google Scholar]
  • 51.Blank MM, Chen L, Papageorge M, et al. The underreporting of cost perspective in cost-analysis research: a systematic review of the plastic surgery literature. J Plast Reconstr Aesthet Surg. 2018;71:366–376. [DOI] [PubMed] [Google Scholar]
  • 52.Joint Commision International. Available at https://www.jointcommissioninternational.org. Accessed on November 24, 2024.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gox-13-e7065-s001.pdf (144.7KB, pdf)
gox-13-e7065-s002.pdf (823.2KB, pdf)
gox-13-e7065-s003.pdf (235.9KB, pdf)

Articles from Plastic and Reconstructive Surgery Global Open are provided here courtesy of Wolters Kluwer Health

RESOURCES